The Impact of Continuous Transcutaneous CO2 (TCCO2) Monitoring in Extremely Low Birth Weight (ELBW) Infants

The Impact of Continuous Transcutaneous CO2 Monitoring (TCCO2) in Extremely Low Birth Weight (ELBW) Infants: A Prospective Observational, Multi-Center Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03477708

Enrollment

166

Registered

2018-03-26

Start date

2018-01-01

Completion date

2022-04-01

Last updated

2022-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ELBW - Extremely Low Birth Weight Infant, IVH- Intraventricular Hemorrhage

Brief summary

An observational study comparing outcomes of Extremely Low Birth Weight (ELBW) infants that were monitored with non-invasive Transcutaneous CO2 (TCCO2) monitor to infants that were not monitored by TCCO2 monitor.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

0 Minutes to 24 Hours

Healthy volunteers

Inclusion criteria

* ELBW infants Need of respiratory support

Exclusion criteria

* Parental refusal IVH before study entry chromosomal abnormalities congenital central nervous system (CNS) abnormalities

Design outcomes

Primary

Measure	Time frame	Description
IVH-Intraventricular Hemorrhage	Repeated scans until infant reaches corrected age of 42 weeks	Intraventricular Hemorrhage
PVL- Periventricular Leukomalacia	Repeated scans until infant reaches corrected age of 42 weeks	Periventricular Leukomalacia

Countries

Israel

Outcome results